Sigma Investment Counselors Inc. Buys 769 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Sigma Investment Counselors Inc. has increased its holdings in UnitedHealth Group by 5.8%, purchasing an additional 769 shares during the second quarter, bringing their total to 14,130 shares valued at $4.4 million.
• Recent analyst upgrades for UnitedHealth Group include a price target increase by Morgan Stanley to $395 and by Mizuho to $430, with a majority of analysts rating the stock as a Buy.
• UnitedHealth Group's most recent earnings report showed EPS of $4.08, missing estimates, with revenues of $111.62 billion, marking a 12.9% year-over-year increase.

Sigma Investment Counselors Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,130 shares of the healthcare conglomerate's stock after purchasing an additional 769 shares during the period. Sigma Investment Counselors Inc.'s holdings in UnitedHealth Group were worth $4,408,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of UNH. Citizens National Bank Trust Department boosted its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after purchasing an additional 170 shares during the period. Caitlin John LLC raised its holdings in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after buying an additional 111 shares during the period. Triumph Capital Management purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $1,324,000. Wealth Effects LLC boosted its position in UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock valued at $1,463,000 after buying an additional 591 shares during the period. Finally, Arlington Partners LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth $2,229,000. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on UNH shares. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Mizuho lifted their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an "outperform" rating in a research note on Thursday, October 9th. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a research report on Thursday, October 9th. The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a "buy" rating and a $406.00 price target on the stock. Finally, Zacks Research raised UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research report on Monday, October 6th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $385.13.

UnitedHealth Group Trading Down 0.0%

UnitedHealth Group stock opened at $356.53 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $322.90 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. The stock has a 50-day moving average price of $329.38 and a 200 day moving average price of $343.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. The company's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.